Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the best NASDAQ stocks with high upside potential. On May 28, Intuitive announced the promotion of Taylor Patton to Chief Commercial and Marketing Officer, effective July 1. Patton, who has spent nearly two decades at the company, previously led the global endoluminal business, including the successful launch of the Ion platform. He will now join the executive leadership team to oversee global commercial operations and marketing strategies.
Current Chief Commercial and Marketing Officer Henry Charlton will transition to the role of Senior Vice President of Global Business Operations. In this new capacity, Charlton will focus on ensuring global value generation for patients and healthcare systems while working closely with Patton to ensure a seamless leadership transition.
CEO Dave Rosa noted that Patton’s extensive experience across the da Vinci, Ion, and Digital platforms makes him well-suited to scale the company’s commercial operations during a period of global growth. This leadership change aligns with Intuitive Surgical Inc.’s (NASDAQ:ISRG) ongoing efforts to expand access to minimally invasive care and support its objective of achieving the “Quintuple Aim” across all geographies.
Intuitive Surgical Inc. (NASDAQ:ISRG) engages in the development, manufacturing, and marketing of da Vinci surgical systems and the Ion endoluminal system.
While we acknowledge the risk and potential of ISRG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ISRG and that has 10,000% upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center